Tavaborole NDC 62332-467

NDC codes

FDA NDC Directory

Product NDC (as listed)62332-467Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62332-0467Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
62332-467-04	62332046704	1 BOTTLE, DROPPER in 1 CARTON (62332-467-04) / 4 mL in 1 BOTTLE, DROPPERMarketed from Oct 23, 2020
62332-467-10	62332046710	1 BOTTLE, DROPPER in 1 CARTON (62332-467-10) / 10 mL in 1 BOTTLE, DROPPERMarketed from Oct 23, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Tavaborole
Generic name (nonproprietary): tavaborole
Active ingredients: Tavaborole — 43.5 mg/mL
Dosage form: Solution
Route: Topical
Labeler: Alembic Pharmaceuticals Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 212188
Marketing start: Oct 23, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Boron Compounds (Chemical structure)Protein Synthesis Inhibitors (Mechanism)
Identifiers: Product ID 62332-467_d35e58d2-869d-40bf-a00e-296a9d3bb659SPL ID d35e58d2-869d-40bf-a00e-296a9d3bb659SPL set ID 22a6617b-d4b1-405e-901a-0b39a7b2837dRxCUI 1543177UNII K124A4EUQ3
Pharmacologic class: Oxaborole Antifungal

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462332046704 followed by a unit qualifier and the quantity

Package 62332-0467-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 15, 2023.

Indications (excerpt from the label)

Tavaborole topical solution, 5% is an oxaborole antifungal indicated for the treatment of onychomycosis of the toenails due to Trichophyton rubrum or Trichophyton mentagrophytes . Tavaborole topical solution is an oxaborole antifungal indicated for the topical treatment of onychomycosis of the toenails due to Trichophyton rubrum or Trichophyton mentagrophytes .

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 212188

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 212188
Product	Strength	Form · route	Labeler	Product NDC
Tavaborole	Tavaborole 43.5 mg/mL	SolutionTopical	Alembic Pharmaceuticals Limited	46708-467